Department of Microbiology, New York University School of Medicine, New York, NY 10016.
Department of Microbiology, New York University School of Medicine, New York, NY 10016
J Immunol. 2019 Aug 1;203(3):593-599. doi: 10.4049/jimmunol.1900345.
Macrophages not only regulate intestinal homeostasis by recognizing pathogens to control enteric infections but also employ negative feedback mechanisms to prevent chronic inflammation. Hence, macrophages are intriguing targets for immune-mediated therapies, especially when barrier function in the gut is compromised to trigger aberrant inflammatory responses, most notably during inflammatory bowel diseases. Recently, there has been considerable progress in our understanding of human macrophage biology in different tissues, including the intestines. In this review, we discuss some new findings on the properties of distinct populations of intestinal macrophages, how resolution of inflammation and tissue repair by macrophages could be promoted by type 2 cytokines as well as other therapeutic interventions, and highlight some challenges for translating these findings into the future for this exciting area of immunology research.
巨噬细胞不仅通过识别病原体来控制肠道感染,从而调节肠道稳态,还采用负反馈机制来防止慢性炎症。因此,巨噬细胞是免疫介导治疗的有趣靶点,尤其是在肠道屏障功能受损引发异常炎症反应时,这种靶点尤其重要,比如在炎症性肠病中就是如此。最近,我们对不同组织(包括肠道)中人类巨噬细胞生物学的理解取得了相当大的进展。在这篇综述中,我们讨论了一些关于肠道巨噬细胞不同群体特性的新发现,巨噬细胞如何通过 2 型细胞因子以及其他治疗干预来促进炎症消退和组织修复,并强调了将这些发现转化为这一激动人心的免疫学研究领域的未来的一些挑战。